Press Releases
22 April
"Go global, come to the UK: British High Commissioner tells India's leading biotech companies"
The British High Commissioner to India, Sir Michael Arthur, today invited India's leading biotechnology companies with global ambitions to seriously look at the UK as a business destination. Speaking at the inaugural session of Bangalore Bio 2005, he said:
"We hope many more biotech/pharma companies establish their offices in UK. The UK delegation to Bangalore Bio 2005 has representatives from some of our bio clusters -- Cambridge, Wales, the Midlands and London. I invite Indian companies wishing to expand their business beyond the shores of India to take advantage of their presence."
Announcing new partnerships between India and UK in the biotech sector, he said:
"The last 5 to 6 years have seen huge changes in both our societies, both our economies, in our international engagement. But the most interesting for the future of this relationship is the changing nature of the economic relationship. Britain has always been one of the biggest inward investors in India - currently third after the US and Mauritius... The latest addition to the list of UK companies in India is Randox Laboratories Ltd, which is setting up its first manufacturing unit outside the UK, in Bangalore.
Today, we have also signed and sealed the business tie-up between Zenosis of UK and EduTech of India, and I am pleased to announce another business tie up between a UK and Indian company in this sector -- Shantha Biotechnics, a leading biotech company in India, has signed an agreement with PolyTherics Ltd, a University of London biotech spin-out company."
Sir Michael said that knowledge sector is one of the key areas for further strengthening ties between India and the UK.
"A strong link between our knowledge cities - for example, Cambridge in the UK and Bangalore in India - would go a long way in strengthening ties both at business and government levels," he said.
Other highlights of Sir Michael's speech include:
"The technology transfer agreement between Shantha Biotechnics and PolyTherics Ltd is a shining example of how exciting innovations in our best universities can be rapidly turned into new and useful global healthcare products."
---
Article published in British High Commission
22 April 2005
[Original article]
This article has been reproduced from the media. It does not necessarily represent the views or position of PolyTherics.
